| Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. | |
| | |
MedLine Citation:
|
PMID: 16109049 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Merck & Co., Inc. evaluates outcomes of the use of rizatriptan during pregnancy through a Pregnancy Registry in the United States (US) and spontaneous reports for pregnancies reported from sources outside the US. Review of the outcomes of 25 prospective pregnancy reports in the Pregnancy Registry and reports from other sources does not suggest that treatment with rizatriptan predisposes patients to spontaneous abortions or congenital anomalies. However, the number of reports is small. Healthcare providers in the United States are encouraged to report any prenatal exposure to rizatriptan by calling the Pregnancy Registry at +1 (800) 986 8999 or visiting the Registry's website at http://www.merckpregnancyregistries.com. |
| | |
Authors:
|
M Fiore; K E Shields; N Santanello; M R Goldberg |
Related Documents
:
|
19083009 - Imatinib use during pregnancy and breast feeding: a case report and review of the liter... 20399009 - Primary meningeal sarcoma with leiomyoblastic differentiation complicating pregnancy. 8776369 - Pruritic urticarial papules and plaques of pregnancy (polymorphic eruption of pregnancy... 20420289 - Heterotopic pregnancy: case report. 16350709 - Hellp syndrome: a report of two cases. 3657659 - Breast cancer and pregnancy. 10632669 - Variations in cytokine mrna expression during normal human pregnancy. 22192399 - Using pgfm (13,14-dihydro-15-keto-prostaglandin f2α) as a non-invasive pregnancy marke... 15198779 - Ultrasonographic occiput position in early labour in the prediction of caesarean section. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cephalalgia : an international journal of headache Volume: 25 ISSN: 0333-1024 ISO Abbreviation: Cephalalgia Publication Date: 2005 Sep |
Date Detail:
|
Created Date: 2005-08-19 Completed Date: 2005-10-12 Revised Date: 2008-02-11 |
Medline Journal Info:
|
Nlm Unique ID: 8200710 Medline TA: Cephalalgia Country: England |
Other Details:
|
Languages: eng Pagination: 685-8 Citation Subset: IM |
Affiliation:
|
Clinical Risk Management and Safety Surveillance, Merck Research Laboratories, West Point 19486, USA. maryellen_fiore@merck.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abnormalities, Drug-Induced
/
epidemiology* Female Humans Pregnancy Pregnancy Outcome / epidemiology* Registries Serotonin Agonists / adverse effects* Triazoles / adverse effects* Tryptamines |
| Chemical | |
Reg. No./Substance:
|
0/Serotonin Agonists; 0/Triazoles; 0/Tryptamines; 145202-66-0/rizatriptan |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Parasuicide, self-harm and suicide in Aboriginal people in rural Australia: a review of the literatu...
Next Document: Facial pain in a neurological tertiary care centre--evaluation of the International Classification o...